Circulating C1QC in cancer: analytical platforms, evidence gaps, and prospects for clinical chemistry translation

Clinica Chimica Acta · Published 2026-06-23 · DOI 10.1016/j.cca.2026.121198

Authors (9)

Isam M. Abu Zeid, Muhammad Afzal, Misbahuddin Rafeeq, Mustafa Zeyadi, Kamel Chaieb, Hisham N. Altayb, Sami I. Alzarea, Muhammad Shahid Nadeem, Imran Kazmi

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Zeid, I., Afzal, M., Rafeeq, M., et al. (2026). Circulating C1QC in cancer: analytical platforms, evidence gaps, and prospects for clinical chemistry translation. Clinica Chimica Acta. https://doi.org/10.1016/j.cca.2026.121198

Related articles

• Comparative stability analysis of RNA in dried blood spots for real-time PCR based molecular testing · Clinica Chimica Acta · 2026 · Same journal
• Specific serum metabolites can differentiate severe and mild human traumatic brain injury · Clinica Chimica Acta · 2026 · Same journal
• Investigating non-reproducible high-sensitivity cardiac troponin T results in real-world practice · Clinica Chimica Acta · 2026 · Same journal
• Plasma nerve growth factor level is associated with functional outcome after ischemic stroke · Clinica Chimica Acta · 2026 · Same journal
• Multiplex methylation marker analysis for ctDNA detection in liquid biopsies from anal cancer patients: an HPV-independent approach · Clinica Chimica Acta · 2026 · Same journal
• Evaluating circulating tumor DNA methylation patterns of a multi-gene panel for colorectal cancer diagnosis: A pilot study · Clinica Chimica Acta · 2026 · Same journal
• Development and commutability assessment of serum-based candidate reference materials for homocysteine and their application in external quality assessment · Clinica Chimica Acta · 2026 · Same journal
• Reference intervals for venous blood gas measurement in a healthy Chinese population · Clinica Chimica Acta · 2026 · Same journal
• Hyperuricemia, circulating metabolites, and the risk of cardiometabolic multimorbidity · Clinica Chimica Acta · 2026 · Same journal
• CRISPR-Cas12a-based liquid biopsy technology: challenges in large-scale clinical application · Clinica Chimica Acta · 2026 · Same journal